Abstract
ObjectiveAtrial fibrillation (AF) is one of the most common side effects of ibrutinib, a drug that has dramatically improved the prognosis of chronic B-cell malignancies such as chronic lymphocytic leukaemia...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have